A glimpse into the future: Integrating artificial intelligence for precision HER2‐positive breast cancer management

A glimpse into the future: Integrating artificial intelligence for precision HER2‐positive breast cancer management

Abstract Breast cancer (BC), specifically HER2‐positives subtype, has a poor prognosis. Nevertheless, the development of anti‐HER2 therapy yielded satisfactory outcomes. Therefore, evaluating patient HER2 status and ascertaining responsiveness to anti‐HER2 therapy is crucial. The advent of deep lear...

Full description

Saved in:
Bibliographic Details
Main Authors: Xinpei Deng, Yixuan Yan, Zekai Zhan, Jindong Xie, Hailin Tang, Yutian Zou, Jian Tu, Peng Liu
Format: Article
Language:English
Published: Wiley 2024-09-01
Series:iMetaOmics
Subjects:
anti‐HER2 therapy
artificial intelligence
breast cancer
image recognition
radiogenomics
Online Access:https://doi.org/10.1002/imo2.19
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/imo2.19

Similar Items